Biomarin Pharmaceutical Inc (BMRN) Insider Trading

Total insider buys:
  • $1,316,196.75
Total insider sells:
  • $342,139,664.94
Most recent insider trade:
  • Nov. 12, 2024
Most active insider trader:
  • Jean Jacques Bienaime
Trader NameDateTitleAmountPriceTypeTotal Value
April 20, 2020Insider17,213$90.00Sell$1,549,170.00
April 9, 2020CEO10,000$79.06Sell$790,600.00
April 8, 2020EVP2,407$79.98Sell$192,511.86
April 1, 2020EVP1,537$82.00Sell$126,034.00
March 24, 2020EVP2,041$74.36Sell$151,768.76
March 17, 2020Director3,750$75.39Sell$282,712.50
March 9, 2020CEO10,000$89.52Sell$895,200.00
Jan. 14, 2020CEO8,000$87.95Sell$703,600.00
Jan. 7, 2020CEO3,000$84.46Sell$253,380.00
Dec. 27, 2019CEO5,000$86.16Sell$430,800.00
Dec. 17, 2019Director3,750$83.36Sell$312,600.00
Nov. 26, 2019EVP3,190$79.66Sell$254,115.40
Nov. 22, 2019CEO10,000$77.60Sell$776,000.00
Oct. 25, 2019CEO5,000$69.55Sell$347,750.00
Sept. 17, 2019Director3,750$74.47Sell$279,262.50
June 17, 2019Director3,750$81.08Sell$304,050.00
May 10, 2019CEO10,000$82.52Sell$825,200.00
May 8, 2019CEO4,000$82.16Sell$328,640.00
April 26, 2019CEO3,000$82.88Sell$248,640.00
April 12, 2019CEO4,000$89.12Sell$356,480.00
April 8, 2019CEO3,000$91.87Sell$275,610.00
April 5, 2019CEO3,000$93.37Sell$280,110.00
April 5, 2019SVP2,953$94.00Sell$277,582.00
April 1, 2019CFO13,473$89.00Sell$1,199,097.00
March 27, 2019CFO100$90.00Sell$9,000.00
March 27, 2019Director2,150$89.76Sell$192,984.00
March 25, 2019EVP3,363$87.86Sell$295,473.18
March 25, 2019Insider5,932$87.86Sell$521,185.52
March 25, 2019CEO4,000$87.86Sell$351,440.00
March 21, 2019EVP4,519$89.98Sell$406,619.62
March 19, 2019EVP3,728$93.07Sell$346,964.96
March 18, 2019Insider9,597$94.09Sell$902,981.73
March 15, 2019CEO4,000$94.40Sell$377,600.00
March 12, 2019CEO9,000$90.06Sell$810,540.00
March 7, 2019CEO4,000$90.78Sell$363,120.00
March 4, 2019Insider2,196$95.00Sell$208,620.00
Feb. 27, 2019CEO4,000$91.78Sell$367,120.00
Feb. 21, 2019CEO3,000$90.12Sell$270,360.00
Feb. 14, 2019CEO4,000$95.20Sell$380,800.00
Feb. 5, 2019CEO4,000$98.63Sell$394,520.00
Jan. 22, 2019CEO3,000$96.82Sell$290,460.00
Jan. 14, 2019CEO4,000$93.79Sell$375,160.00
Jan. 10, 2019CEO3,000$90.55Sell$271,650.00
Jan. 7, 2019CEO3,000$87.58Sell$262,740.00
Dec. 28, 2018CEO3,000$84.04Sell$252,120.00
Dec. 28, 2018CEO3,000$84.04Sell$252,120.00
Dec. 27, 2018Director2,150$82.53Sell$177,439.50
Dec. 26, 2018CEO4,000$80.50Sell$322,000.00
Dec. 14, 2018CEO2,000$92.64Sell$185,280.00
Dec. 12, 2018CEO2,000$93.12Sell$186,240.00
  • Insiders are both buying and selling Biomarin Pharmaceutical Inc stock.

  • The insider traders at Biomarin Pharmaceutical Inc are: Jean Jacques Bienaime, Jeffrey Robert Ajer, George Eric Davis, Henry J Fuchs, Daniel K Spiegelman, V Bryan Lawlis, Brian Mueller, Robert Baffi, Henry Fuchs, Mark Wood, Richard A Meier, Michael G Grey, Alan Lewis, Charles Greg Guyer, Elaine J Heron, Henry J. Fuchs, Mark J Alles, Erin Burkhart, Dennis Slamon, Mueller Brian, Davis George Eric, David E I Pyott, Daniel K. Spiegelman, and Willard H Dere

  • The most active insider trader at Biomarin Pharmaceutical Inc is Jean Jacques Bienaime with 153 trades.

  • Jean Jacques Bienaime has sold the most Biomarin Pharmaceutical Inc stock with a total value of $179,727,061.76.

  • David E I Pyott has bought the most Biomarin Pharmaceutical Inc stock with a total value of $2,003,456.00.

  • The most recent insider trade for Biomarin Pharmaceutical Inc was on Nov. 12, 2024.

  • The single biggest insider buy for Biomarin Pharmaceutical Inc was from David E I Pyott with a total value of $1,001,728.00 on Aug. 31, 2020.

  • The single biggest insider sell for Biomarin Pharmaceutical Inc was from Henry J Fuchs with a total value of $16,430,570.00 on July 20, 2020.